AbbVie lifts full-year profit outlook amid strong psoriasis drug demand
PositiveFinancial Markets
AbbVie has raised its full-year profit outlook, driven by strong demand for its psoriasis drug. This positive news reflects the company's robust performance in the pharmaceutical market, highlighting the effectiveness of its treatments and the growing need for solutions in dermatology. Investors and stakeholders are likely to view this as a sign of AbbVie's continued growth and innovation in addressing chronic conditions.
— Curated by the World Pulse Now AI Editorial System









